112 related articles for article (PubMed ID: 1524950)
1. Immunological analysis and clinical effects of intraabdominal and intrapleural injection of lentinan for malignant ascites and pleural effusion.
Oka M; Yoshino S; Hazama S; Shimoda K; Suzuki T
Biotherapy; 1992; 5(2):107-12. PubMed ID: 1524950
[TBL] [Abstract][Full Text] [Related]
2. [Clinical effects and immunological analysis of intraabdominal and intrapleural injection of lentinan for malignant ascites and pleural effusion of gastric carcinoma].
Hazama S; Oka M; Yoshino S; Iizuka N; Wadamori K; Yamamoto K; Hirazawa K; Wang F; Ogura Y; Masaki Y
Gan To Kagaku Ryoho; 1995 Sep; 22(11):1595-7. PubMed ID: 7574768
[TBL] [Abstract][Full Text] [Related]
3. [Effect of intrapleural and/or intraperitoneal lentinan therapy in carcinomatous pleuritis and peritonitis].
Yoshino S; Oka M; Hazama S; Suzuki T
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1588-91. PubMed ID: 2389953
[TBL] [Abstract][Full Text] [Related]
4. [Effect of intrapleural and/or intraperitoneal lentinan therapy on carcinomatous pleuritis and peritonitis with special reference to immunological evaluation].
Yoshino S; Oka M; Hazama S; Suzuki T
Nihon Geka Hokan; 1989 May; 58(3):310-9. PubMed ID: 2619436
[TBL] [Abstract][Full Text] [Related]
5. [Intrapleural transfer of LAK cells combined with rIL-2 in the treatment of advanced lung cancer with malignant pleural effusion].
Li DJ
Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):294-6. PubMed ID: 2625114
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Efficacy and Safety for Lentinan in the Control of the Malignant Pleural Effusions via Intrapleural Injection.
Congcong Q; Hengting Z; Shuhui L; Fang Y; Shan W
Am J Med Sci; 2019 Dec; 358(6):400-411. PubMed ID: 31813467
[TBL] [Abstract][Full Text] [Related]
7. The characterization of peritoneal and pleural exudate cells from malignant effusions.
Oka M; Yoshino S; Hazama S; Shimoda K; Suzuki T
Surg Today; 1993; 23(6):500-3. PubMed ID: 8102920
[TBL] [Abstract][Full Text] [Related]
8. Intracavitary bleomycin in the management of malignant effusions: a multicenter study.
Ostrowski MJ; Halsall GM
Cancer Treat Rep; 1982 Nov; 66(11):1903-7. PubMed ID: 6182995
[TBL] [Abstract][Full Text] [Related]
9. Induction of endogenous lymphokine-activated killer activity by combined administration of lentinan and interleukin 2.
Suzuki M; Higuchi S; Taki Y; Taki S; Miwa K; Hamuro J
Int J Immunopharmacol; 1990; 12(6):613-23. PubMed ID: 2272726
[TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation of intrapleural or peritoneal repetitive administration of Lentinan and OK-432 for malignant effusion].
Kawaoka T; Yoshino S; Kondo H; Yamamoto K; Hazama S; Oka M
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1565-7. PubMed ID: 16315870
[TBL] [Abstract][Full Text] [Related]
11. Enhanced induction of lymphokine-activated killer activity after lentinan administration in patients with gastric carcinoma.
Arinaga S; Karimine N; Takamuku K; Nanbara S; Inoue H; Nagamatsu M; Ueo H; Akiyoshi T
Int J Immunopharmacol; 1992 May; 14(4):535-9. PubMed ID: 1521921
[TBL] [Abstract][Full Text] [Related]
12. [Intrapleural and intraperitoneal instillation of nitrogen mustard in palliative treatment of malignant effusions].
Jordan E; Karnicka-Mlodkowska H
Pol Tyg Lek; 1971 May; 26(18):676-8. PubMed ID: 4103813
[No Abstract] [Full Text] [Related]
13. Intracavitary bleomycin for the control of malignant effusions.
Bitran JD; Brown C; Desser RK; Kozloff MF; Shapiro C; Billings AA
J Surg Oncol; 1981; 16(3):273-7. PubMed ID: 6163930
[TBL] [Abstract][Full Text] [Related]
14. [Clinical evaluation of intrapleural or peritoneal administration of lentinan and OK-432 for malignant effusion].
Kawaoka T; Yoshino S; Hazama S; Tangoku A; Oka M
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1562-5. PubMed ID: 14619464
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of lymphokine-activated killer cell activity by lentinan.
Tani M; Tanimura H; Yamaue H; Tsunoda T; Iwahashi M; Noguchi K; Tamai M; Hotta T; Mizobata S
Anticancer Res; 1993; 13(5C):1773-6. PubMed ID: 8267381
[TBL] [Abstract][Full Text] [Related]
16. Intracavitary adriamycin nitrogen mustard and tetracycline in the control of malignant effusions: a randomized study.
Kefford RF; Woods RL; Fox RM; Tatterall MH
Med J Aust; 1980 Oct; 2(8):447-8. PubMed ID: 7010099
[No Abstract] [Full Text] [Related]
17. Induction of lymphokine-activated killer cells by intrapleural instillations of recombinant interleukin-2 in patients with malignant pleurisy due to lung cancer.
Yasumoto K; Mivazaki K; Nagashima A; Ishida T; Kuda T; Yano T; Sugimachi K; Nomoto K
Cancer Res; 1987 Apr; 47(8):2184-7. PubMed ID: 3493843
[TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of the combination treatment of intrapleural or intraperitoneal administration of lentinan and OK-432 for malignant effusion].
Yoshino S; Yoshida S; Maeda N; Maeda Y; Maeda K; Hazama S; Oka M
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2798-800. PubMed ID: 21224717
[TBL] [Abstract][Full Text] [Related]
19. [Effects of endoscopic intratumoral injection of lentinan in patients with gastric cancer].
Inagaki T; Morise K; Matsunaga H
Gan To Kagaku Ryoho; 1988 Feb; 15(2):319-24. PubMed ID: 3257678
[TBL] [Abstract][Full Text] [Related]
20. The intrapleural administration of recombinant interleukin-2 (rIL-2) to patients with malignant pleural effusion: clinical trials.
Suzuki H; Abo S; Kitamura M; Hashimoto M; Izumi K
Surg Today; 1993; 23(12):1053-9. PubMed ID: 8118118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
